key: cord-0285677-2756luaj authors: Supardi, S.; Nidom, R. V.; Sisca, E. M.; Tribowo, J. A.; Kandar, P. S.; Budiharto, J. M.; Siswidiyanto, E. B.; Wen, M. D.; Kirana, T.; Nidom, A. N.; Ansori, A. N. M.; Normalina, I.; Indrasari, S.; I'tishom, R. title: Novel Investigation of SARS-CoV-2 in COVID-19 Survivors' Semen in Surabaya, Indonesia date: 2021-10-11 journal: nan DOI: 10.1101/2021.10.08.21264593 sha: 9e9423162cf3ffaba35da1a51ff331fe4ef06f7e doc_id: 285677 cord_uid: 2756luaj The emergence and the widespread of Coronavirus disease 2019 (COVID-19) demands an accurate detection method to establish a diagnosis. Real-time polymerase chain reaction (real-time PCR) is accounted for the perfect point of reference in detecting this virus. The notion that this virus also invades the male reproductive tract requires further investigation to prove the presence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in the semen. This investigation was designed to detect SARS-CoV-2 in COVID-19 survivors semen. This study design was a cross-sectional examination and conducted between November 2020 and March 2021 in the Andrology Unit of Dr. Soetomo General Hospital and Professor Nidom Foundation, both located in the City of Surabaya, Indonesia. The sample was 34 male participants aged above 18 years old and had been confirmed COVID-19 by nasopharyngeal swab PCR test. Part of the semen was taken for real-time PCR testing with the QuantStudio 5 Applied Biosystem (AB) PCR machine and the kits utilized were the STANDARD M nCOV Real-Time Detection Kit and mBioCov-19 RT-PCR Kit. Furthermore, the mean of participants ages was 35.74 years old with 25% of them had had a history of primary infertility and 21.8% of secondary infertility. From the real-time PCR COVID-19 of the semen examination, this investigation found that 27 participants had been negatives (74.4%), six inconclusive (17.6%), and one positive (3%) of SARS CoV-2. In summary, SARS-CoV-2 could be found in the semen of COVID-19 survivors. This should be a concern for the potential impact of COVID-19 in male fertility and the possibility of transmission reproductively. The emergence and the widespread of Coronavirus disease 2019 (COVID-19) demands an 24 accurate detection method to establish a diagnosis. Real-time polymerase chain reaction 25 (real-time PCR) is accounted for the perfect point of reference in detecting this virus. The 26 notion that this virus also invades the male reproductive tract requires further investigation to 27 prove the presence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in the 28 semen. This investigation was designed to detect SARS-CoV-2 in COVID-19 survivors' 29 semen. This study design was a cross-sectional examination and conducted between 30 November 2020 and March 2021 in the Andrology Unit of Dr. Soetomo General Hospital and 31 Professor Nidom Foundation, both located in the City of Surabaya, Indonesia. The sample 32 was 34 male participants aged above 18 years old and had been confirmed COVID-19 by 33 nasopharyngeal swab PCR test. Part of the semen was taken for real-time PCR testing with 34 the QuantStudio 5 Applied Biosystem (AB) PCR machine and the kits utilized were the 35 STANDARD M nCOV Real-Time Detection Kit and mBioCov-19 RT-PCR Kit. 36 Furthermore, the mean of participants' ages was 35.74 years old with 25% of them had had a 37 history of primary infertility and 21.8% of secondary infertility. From the real-time PCR 38 COVID-19 of the semen examination, this investigation found that 27 participants had been 39 negatives (74.4%), six inconclusive (17.6%), and one positive (3%) of SARS CoV-2. In 40 summary, SARS-CoV-2 could be found in the semen of COVID-19 survivors. This should be 41 a concern for the potential impact of COVID-19 in male fertility and the possibility of 42 transmission reproductively. 43 44 45 46 47 48 49 COVID-19 occurs as the result of contagiousness from severe acute respiratory syndrome 50 coronavirus-2 (SARS-CoV-2) spread abruptly and became a global pandemic since 51 December 2019 as the first report of the emergence of this virus in Wuhan [1, 2] analysis utilizes specimens generated from saliva; the swabbing activity of nasal, trachea and 69 nasopharyngeal; tissues of lungs; blood; semen; and even; excrement. [12, 13] . The extraction 70 process of ribonucleic acid (RNA) in the specimen starts from the purification process of 71 total RNA into viral RNA and host RNA, then continued by reversed transcription into the 72 complementary DNA (cDNA) and followed by amplification using the polymerization of 73 chain reaction which is the foundation of real time reverse transcription-polymerase chain 74 reaction (rRT-PCR) examination. [14] . Although rRT-PCR is the most widely used and 75 recommended as the barometer of SARS COV-2 diagnostics, it also has drawbacks. Errors in 76 the preparation, analysis, and interpretation stages will give false positive or false negative or 77 inconclusive rRT-PCR results [15, 16] . 78 Unlike rRT-PCR examination of nasopharyngeal specimens which is routinely performed, 79 the use of rRT-PCR in semen specimens is still limited and is more for research purposes. Moreover, PCR examination was carried out in two stages. In the first stage, PCR 124 examination of semen sample code 1-15 was performed on January, 2021 and in the second 125 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 2 ). 147 Furthermore, the average of interval duration between positive or inconclusive rRT for 148 nasopharyngeal PCR and rRT for semen PCR with positive or inconclusive results was 149 113.28 days. The fastest interval duration between positive and inconclusive nasopharyngeal 150 PCR and semen PCR was 53 days, while the longest interval duration to produce positive or 151 inconclusive PCR was 186 days ( (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 11, 2021. Pneumonia on Chest X-ray 3 (8.82%) All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. were detected positive in the semen during the acute phase. In this study, the discovery of one 203 participant who was positive for SARS COV-2 in the semen has similarities with the study of 204 Gacci et al. (2021) where there was only one participant who was positive for SARS COV-2 205 in the semen, but when the nasopharyngeal PCR test was evaluated, the results were negative 206 [18]. Whereas in this investigation, a nasopharyngeal PCR for reevaluation was not 207 performed on this patient. 208 Additionally, one participant in this study complained on the testicular pain at initial 209 symptom onset. In other study, it was found there were 6 cases of orchitis from the autopsy of 210 SARS patients [25] . This spread in the reproductive tract is probably related to viral loads in 211 the body and related to the infectious process ( Figure 3 and Figure 4) [26]. 212 Since most of the participants were detected negative for semen PCR (74.4%), this was 213 probably because the recruited participants had already passed the recovery phase. 214 Furthermore, the results of rRT PCR were more often negative because there was only <1% 215 chance of detecting positivity in the semen [15, 16] . 216 Finally, the weakness in this current investigation was that the transport of the samples did 217 not use a cold chain box, thus, there was an opportunity for errors occurring at the pre-218 analytic stage. This PCR examination was not examined when the sample first received, 219 instead it was stored in the refrigerator for several days. Participants with positive PCR 220 results in semen were no longer confirmed by nasopharyngeal PCR, therefore, it was not 221 known whether there was a recurrent positive. 222 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 11, 2021. In summary, SARS-CoV-2 could be found in the semen of COVID-19 survivors. It should be 229 noted that PCR is influenced by preanalytical, analytical, and interpretive circumstances. The 230 SARS-CoV-2 existence in the semen sample requires to be further evaluated in future study, 231 as this could be a concern for the consequences of COVID-19 on male fertility status and the 232 possibility of sexual transmission. 233 234 The utilized data to contribute in this investigation are available from the corresponding 236 author on reasonable request. 237 238 The authors declare that there is not any conflict of interest in this study. 240 241 The authors would like to convey gratitude to all employees at the Andrology Unit, Dr. 243 Soetomo An updated investigation prior to 253 COVID-19 vaccination program in Indonesia: Full-length genome mutation analysis of 254 SARS-CoV-2. bioRxiv Viroinformatics investigation of B-cell epitope conserved region in SARS-258 CoV-2 lineage B. 1.1. 7 isolates originated from Indonesia to develop vaccine candidate 259 against COVID-19 Characterization of the spike glycoprotein and construction 262 of an epitope-based vaccine candidate against Indonesian SARS-CoV-2: In silico study 265 Investigation of the D614G mutation and antibody-dependent enhancement sequences in 266 indonesian SARS-CoV-2 isolates and comparison to southeast Asian isolates Nidom 269 CA. Recent updates on COVID-19 vaccine platforms and its immunological aspects: A 270 review Immunoinformatic investigation of three structural protein 273 genes in Indonesian SARS-CoV-2 isolates COVID-19 and multiorgan response Study of SARS-CoV-2 in semen and urine samples of a volunteer with 278 positive naso-pharyngeal swab Clinical characteristics of 24 asymptomatic infections with 281 COVID-19 screened among close contacts in Nanjing Real-time RT-PCR in COVID-19 detection: Issues affecting 284 the results Real-time reverse transcription-polymerase chain reaction 288 assay for SARS-associated coronavirus Trends in MERS-CoV COVID-19) diagnosis strategies: A patent review. Front Public 292 Health CoV-2 in seminal fluid COVID-19 diagnostics in context Potential preanalytical and analytical vulnerabilities 299 in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) Updates on laboratory 302 investigations in coronavirus disease 2019 (COVID-19) A systematic review on the investigation of SARS-CoV-2 in semen Semen impairment and occurrence of SARS-CoV-2 311 virus in semen after recovery from COVID-19 No detection of SARS-CoV-2 from urine, 314 expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A 315 perspective and urogenital evaluation Clinical characteristics and results of semen tests 317 among men with Coronavirus Disease Prognostic factors for severe 319 Prognostic factors for severity and mortality in patients 323 infected with COVID-19: A systematic review Inconclusive SARS-COV-2 reverse 325 transcription-polymerase chain reaction test reports: Interpretation, clinical and infection 326 control implications Comparison of World Health Organization and Asia-Pacific body mass index 329 classifications in COPD patients Orchitis: A complication of 331 severe acute respiratory syndrome (SARS) SARS-333 CoV2 testing: The limit of detection matters